ABSTRACT
INTRODUCTION
tRNA molecules are extensively modified after transcription. In addition to 5Ј-and 3Ј-end maturation, CCA addition, and splicing of introns, all tRNAs contain a number of nucleoside modifications (Bjork 1995; Grosjean et al. 1997; Hopper and Phizicky 2003) . In Saccharomyces cerevisiae, 25 different modifications of base or sugar moieties have been identified within the 34 tRNA species that have been characterized (Sprinzl et al. 1998) , and every tRNA molecule has some subset of these modifications, altering nucleoside identity at an average of 11 positions. Some modifications such as i 6 A or m 2 2 G occur only at a single position in one or more tRNAs, whereas other modifications such as ⌿ occur at a number of different positions in tRNAs (Sprinzl et al. 1998) . The identity and position of many of these modifications are highly conserved; however, despite their widespread conservation, the role that these modifications play in the cell is not fully understood.
One modification of interest is methylation of guanosine (G) at the N-1 position of the base (m 1 G; Fig. 1A ). This modification occurs at two locations in tRNAs. m 1 G is found at position 37 in several tRNAs from all three major kingdoms. It is also found at position 9 in several cytoplasmic tRNAs from all eukaryotes that have sequenced tRNAs, in mitochondrial tRNAs from several animal species, in two vertebrate viral tRNAs, and in tRNA from at least one archaeal species (Sprinzl et al. 1998 ). In the yeast S. cerevisiae, m 1 trm5 mutants are each severely compromised for growth (Bjork et al. 2001) .
The goal of this work was to identify the gene and protein responsible for m 1 G 9 formation in S. cerevisiae tRNA. It is known that the yeast m 1 G 37 methyltransferase plays no role in m 1 G 9 formation in yeast (Bjork et al. 2001) . Furthermore, unlike the case with many other modification enzymes, there is no obvious candidate gene in the yeast database with homology to the known m 1 G 37 methyltransferases (Bjork et al. 2001 ) that might be responsible for m 1 G 9 methylation of tRNAs. Using a biochemical genomics approach, we show here that the protein encoded by ORF YOL093w catalyzes tRNA m 1 G methyltransferase activity in vitro at position 9 of tRNA substrates, and that this protein (Trm10p) is responsible for m 1 G formation at position 9 in yeast tRNAs in vivo.
RESULTS
To determine the protein responsible for catalyzing the modification of tRNA at G 9 to m 1 G, we first developed a sensitive assay using yeast tRNA Gly , a tRNA that is known to contain m 1 G 9 in vivo (Sprinzl et al. 1998 ). This tRNA was synthesized in vitro and then uniquely labeled at the phosphate immediately 3Ј of G 9 , by directing cleavage at this position with RNase H, labeling the 5Ј nucleotide of the resulting 3Ј RNA product, and reforming the tRNA by ligation, as described in Materials and Methods (Yu 1999) . After incubation of G 9 *Gly tRNA with a source of m 1 G 9 methyltransferase activity (crude yeast extracts or purified protein) in the presence of the methyl donor S-adenosylmethionine (SAM), RNA was treated with a combination of RNase T2 and RNase A, and nucleoside 3Ј-monophosphate products were resolved on cellulose TLC plates (Fig. 1B) . Because G 9 was the only labeled nucleotide in this substrate, modification of the tRNA at this position is easily detected by looking for a change in mobility of the labeled spot. As shown in Figure 2A (lanes a and b), treatment of tRNA with yeast crude extract results in the quantitative conversion of Gp* to a modified product that migrates significantly more slowly in the solvent system. This modification was presumed to be m 1 Gp*, which will be demonstrated below.
Identification of a yeast ORF associated with an activity that modifies position 9 of tRNA Gly
To identify the protein responsible for this modification activity, we screened a library of purified yeast GST-ORF fusion proteins for the activity, as has been done for a number of other activities (Martzen et al. 1999; Alexandrov et al. 2002; Hazbun and Fields 2002; Xing et al. 2002) . This library is an ordered collection of 6144 yeast strains each expressing a predicted yeast open reading frame (ORF) as a GST-ORF fusion protein. For ease of assaying more than 6000 proteins, the library of strains is grown in pools derived from each microtiter plate, such that after purification each pool contains a mixture of 96 individual GST-ORF fusion proteins. After activity is observed in one pool, fur- Reaction mixtures containing G 9 *Gly tRNA and protein as indicated were incubated in methyltransferase buffer at 30°C for 4 h, and then RNA was digested with nucleases to produce 3Ј-phosphorylated nucleotides, which were resolved by thin layer chromatography. (A) Assay of a genomic collection of pools of purified yeast GST-ORF fusion proteins for G 9 methyltransferase activity. Substrate G 9 *Gly tRNA was incubated with 64 pools of purified GST-ORF fusion proteins, each derived from 96 yeast strains of a library of strains expressing individual GST-ORF fusion proteins, as indicated. Gly uniquely labeled at position 9 (G 9 *Gly). This assay results in the production of either Gp* if the substrate remains unmodified, or m ther deconvolution leads to the identification of the individual fusion protein responsible for the activity. When the GST-ORF pools were screened for the modification activity that altered G 9 of tRNA Gly , a positive signal was observed in pool 47 ( Fig. 2A) . To determine the individual ORF responsible for this modification, we assayed 8 subpools of 12 proteins comprising each row (A-H) of plate 47 and 12 subpools of 8 proteins comprising each column (1-12) of plate 47. Activity was detected in row E and column 6 (Fig.  2B) . To confirm the assignment of the activity to the strain at position E6, the corresponding strain (MRM4470) was grown, and extracts were analyzed for activity. Crude extracts made from this strain overexpress tRNA m 1 G 9 methyltransferase activity at least fivefold relative to wild-type strains (data not shown), demonstrating that the corresponding ORF, YOL093w, is the limiting factor required for activity. The protein encoded by YOL093w has no previously identified function in yeast; we have assigned it the name TRM10 because, as we show below, its protein product is the tRNA m 1 G 9 methyltransferase.
Trm10p is necessary for modification of position 9 of tRNA
Gly and has no effect on modification of position 37
To determine if Trm10p is required for modification at position 9, we prepared extracts from the homozygous trm10-⌬/trm10-⌬ strain and its isogenic TRM10 + /TRM10 + parent strain, and compared their activities with the tRNA Gly substrate (G 9 *Gly) used above. Extracts from wildtype cells were active with the G 9 *Gly substrate when diluted as much as 125-fold, whereas G 9 modification activity was undetectable in the trm10-⌬/trm10-⌬ strain even at the highest concentration of extract tested (Fig. 3A) . This is consistent with the identification of Trm10p as the protein responsible for G 9 modification activity.
Because yeast tRNA also contains m 1 G at position 37 of some tRNA species, we investigated the site specificity of the reaction using a tRNA CAA Leu substrate normally modified by Trm5p to m 1 G at position 37. Although our in vitro assay for Trm5p activity uses a similar uniquely labeled substrate (G 37 *Leu) and similar conditions, we consistently observe much lower levels of Trm5 methyltransferase activity than we observe with Trm10p and its substrate. Nonetheless, m 1 G 37 methyltransferase activity can be observed by using longer incubation times (Fig. 3B) . Assay of the wildtype and trm10-⌬/trm10-⌬ extracts with the G 37 *Leu substrate indicates no difference in m 1 G 37 methyltransferase activity between them, as expected if the modification activity of Trm10p is specific for position 9 (Fig. 3B) . We note that because the modification at G 37 of tRNA CAA Leu is known to be m 1 G (Bjork et al. 2001) , the identical migration of the products observed with the two different substrates is consistent with the modification at position 9 also being m 1 G.
Trm10p is sufficient for m 1 G 9 modification in vitro
To determine if Trm10p could catalyze modification of tRNA without additional S. cerevisiae proteins, the ORF was cloned into a pET14b-based vector for production of the protein in Escherichia coli. This plasmid, pJEJ12-3, expresses soluble His 6 -Trm10 fusion protein when introduced into BL21(DE3)pLysS cells and induced for expression, as observed by SDS-PAGE of extracts (Fig. 4A, lanes 1,2) . The prominent new band in lane 2 has a molecular mass consistent with the predicted molecular mass of 35.5 kD for the His 6 -Trm10 fusion protein. Assays of extracts demonstrated a >1000-fold increase in G 9 *Gly modification activity from cells expressing His 6 -Trm10p compared with cells with vector alone (Fig. 4B ). As shown in Figure 4B , there was no background m 1 G 9 methyltransferase activity in extracts made from cells containing the control vector; this is as expected because E. coli cells do not contain an m 1 G 9 modification in their tRNAs.
The His 6 -Trm10 fusion protein was purified from extracts with immobilized metal-ion affinity chromatography (IMAC; Fig. 4A , lanes 5,6). The purified protein is nearly homogeneous, has an increased specific activity of about twofold over the original extract (Fig. 4A , lanes 4-6), and is obtained at 30% yield (data not shown), indicating that Trm10p is sufficient for catalysis in vitro in the absence of other interacting partners. The activity of the purified protein from E. coli is completely dependent on the addition of 0.5 mM SAM in the assay, although this dependence is only apparent at low enzyme concentrations, where the enzyme is required to undergo multiple turnovers during the course of the reaction (data not shown). This indicates that some amount of bound SAM copurifies with Trm10p and therefore that Trm10p is able to bind SAM with some degree of affinity. Gly with Trm10p purified from E. coli in a reaction mixture containing 10 µM tRNA and 10 µM Trm10p, and then analyzed nucleosides from the product tRNA by HPLC (Fig. 5A , bottom two traces). Unmodified tRNA Gly contains four main peaks for the four expected nucleosides C, U, G, and A, whereas the Trm10p-modified tRNA contains an additional peak that comigrates with and has a spectrum identical to an m Gly (m 5 C and Cm) were identified based on retention time and spectrum of the respective peaks and are labeled in Figure 5B . Quantitation of the amount of modified nucleosides apparent in these tRNAs indicates that <1% m 1 G remains in tRNA
Gly isolated from the trm10-⌬/trm10-⌬ cells, whereas all other nucleotide modifications remain essentially unchanged, except for dihydrouridine levels, which are slightly altered between the two samples but well within the variation observed because of its proximity to pseudouridine and lack of a clear absorption peak (Table 1) . For tRNA from both wild-type and trm10-⌬ strains, we reproducibly observe a higher than expected amount of m G, because the N-1 methyl group of the m 1 G residue impairs its ability to form the normal Watson-Crick base pair necessary for continued extension by reverse transcriptase (RT). Because primers used in this assay are specific for an individual tRNA species, this assay allows for rapid analysis of the modification status of multiple tRNAs in a single preparation of bulk RNA. We tested this method by probing tRNA
Gly from bulk preparations of RNA, using a primer that could hybridize to it at a region ending in the D-loop (shown in bold in Fig.  6A ). With tRNA from wild-type cells, a block to primer extension was observed at position G 10 (corresponding to C in the sequencing ladder shown in Fig. 6A ), because the presence of m 1 G 9 has prevented RT from reading past the modified nucleotide. However, with RNA from the trm10-⌬/trm10-⌬ strain, this primer is extended through G 9 to the 5Ј-end of the tRNA, as expected because of the presence of an unmodified G 9 in tRNA Gly from this strain ( Fig. 5B ; Table 1 Arg from wild-type cells is blocked before reaching the 5Ј-end of the RNA, at a position consistent with the presence of m 1 G 9 in these tRNA species (Fig. 6B ). This primer extension block is completely absent in tRNA from trm10-⌬/trm10-⌬ cells, strongly implying a quantitative loss of m 1 G 9 in these cells (Fig. 6B) . The same results were observed with the other five tRNA species examined (data not shown). In contrast, control primer extension assays with primers targeting tRNAs that do not contain m 1 G 9 exhibit only the primer extension stop at the 5Ј-end of the tRNA in RNA derived from either the wildtype or the trm10-⌬/trm10-⌬ strain (Fig. 6B, , and both tRNA UCU Arg species; data not shown), the block appeared as more of a stutter rather than as the block at a single site observed with tRNA Gly (Fig. 6A) , tRNA Val , tRNA Trp (Fig. 6B) , and tRNA Pro (data not shown). This may reflect a sequencespecific variability in the way AMV-RT deals with the presence of m 1 G in various sequences; variation in the response of RT to sequences that act as blocks to primer extension has been observed previously (Lorsch et al. 1995 ). These results demonstrate that TRM10 is required for the catalysis of at least 9 of the 10 m 1 G modifications observed at position 9 in yeast. It is likely that Trm10p is also responsible for modification of G 9 of tRNA Ala .
Specificity of Trm10p activity in vivo
The primer extension assay has also been used to confirm that Trm10p is not involved in modification of G 37 in vivo. Primers were used to target two tRNA species known to be substrates for Trm5p: tRNA UAG Leu , which contains m 1 G 37 , and tRNA
Phe , which contains Y 37 (wybutosine), the synthesis of which is initiated by formation of m 1 G 37 by Trm5p (Bjork et al. 2001) . Primer extension assays demonstrated that the extent of m 1 G 37 modification is unchanged in strains lacking Trm10p (Fig. 6C ). This result was confirmed by HPLC analysis of nucleosides generated from another tRNA known to contain m 1 G 37 , tRNA CAA Leu ; the m 1 G content of this tRNA is similar when purified from wild-type or trm10-⌬/trm10-⌬ cells (data not shown).
Effects of loss of m 1 G 9 on cell viability
As we have shown above, Trm10p is the major, if not the only, m 1 G 9 tRNA methyltransferase acting in S. cerevisiae cells. However, trm10-⌬/trm10-⌬ strains do not exhibit any obvious growth defect when compared with their isogenic TRM10 + /TRM10 + parent strain in rich media and in minimal media at several different temperatures (data not shown). In contrast, a trm5-⌬ strain grows extremely slowly (Bjork et al. 2001 ).
The Trm10 methyltransferase family is widely conserved, but is not homologous to the yeast m 1 G 37 methyltransferase, Trm5
Iterative BLAST searches show that Trm10p is a member of a family of proteins found widely in all free-living eukaryotes (but not in the obligate parasite microsporidia, Encephalitozoon cuniculi) and half of all archaeal species sequenced ( Fig. 7) but not in any Eubacteria. Indeed, this family of proteins has been described in both the PFAM Gly from wild-type and trm10-⌬/ trm10-⌬ strains. tRNA
Gly was purified from wild-type and trm10 mutant strains, and its nucleosides were prepared and resolved on HPLC as described above. (Sprinzl et al. 1998). b Calculated from areas under peaks observed upon HPLC elution of nucleosides, as described in Materials and Methods. database (DUF 425) and the COGs (Cluster of Orthologous Groups, COG2419) database as being conserved, albeit with no ascribed function. Unexpectedly, the database searches also revealed the presence of multiple TRM10-like homologs in each of several metazoan genomes. For instance, the human and mouse genomes harbor at least three homologs, whereas mosquito, fruit fly, and nematode genomes possess at least two. The occurrence of multiple Trm10p family members in metazoans is unexpected because Trm10p is responsible for most, if not all, of the m 1 G 9 tRNA methylation observed in yeast (Fig. 6) .
The presence of the archaeal and multiple metazoan homologs prompted a phylogenetic reconstruction of the evolution of this family, presented in Figure 8 . In this phylogeny, the archaeal and eukaryotic homologs clearly group separately from one another. In addition, it is apparent that at least one of the lineages found in metazoans (human #3 in Fig. 8 ) appears to branch separately from those that group the human homologs #1 and #2 with yeast Trm10p. This implies two possibilities: either this lineage of proteins predates the human-yeast split; or it has rapidly evolved, causing its phylogenetic placement to be artifactual. Comparison of the human-mouse orthologs for each of lineages 1, 2, and 3 indicates that all three pairs are evolving under similar evolutionary constraints, supporting the argument against artifactual placement in the tree. Therefore, we conclude that there were at least two separate lineages of Trm10-like proteins in eukaryotes, only one of which has been retained in protists, fungi, and plants, whereas metazoans continue to harbor both. One of the Caenorhabditis elegans homologs branches even earlier than the two metazoan lineages, but this may be caused by rapid evolution rather than an ancient divergence, as is the case for a number of C. elegans genes (Blaxter et al. 1998) .
Remarkably, database searches, pairwise BLAST, and comparisons of multiple alignments do not identify even any remote homology between Trm10p and Trm5p, the S. cerevisiae m 1 G 37 methyltransferase (Bjork et al. 2001 ; see Materials and Methods); thus, these two proteins are likely unrelated, despite their conserved biochemical activity (see also Discussion). We note also that Trm10p was not identified in a search for SAM-dependent methyltransferases in S. cerevisiae based on known SAM binding motifs (Niewmierzycka and Clarke 1999) , and that none of our searches revealed any similarity with known methyltransferases. Because Trm10p requires SAM, this indicates that Trm10p may contain a more subtle or a different SAMbinding sequence.
DISCUSSION
We have shown that S. cerevisiae Trm10p, encoded by YOL093w, catalyzes the methylation of G residues to m 1 G in tRNA Gly at position 9. Using a substrate that is uniquely labeled with 32 P at the junction between residues 9 and 10, S-adenosylmethionine as a methyl donor, and assays of a genomic array of GST-fusion proteins, we have identified the corresponding protein and gene (Fig. 2) . Cloning of this gene and subsequent overproduction of Trm10p activity in E. coli demonstrates that Trm10p alone is sufficient for catalysis of m 1 G 9 methylation in vitro (Fig. 4) . The product of the Trm10p reaction is m 1 G, based on comparison of the TLC mobility of the RNase T2 digestion product m 1 Gp with that produced by modification of G 37 of tRNA Leu to m 1 G in extracts (Fig. 3) , and on comparison of the HPLC mobility (Fig. 5 ). Our data also show that Trm10p is specific for G 9 of tRNA substrates. Extracts from trm10-⌬/trm10-⌬ strains lack m 1 G 9 methyltransferase activity but have m 1 G 37 methyltransferase activity, as expected if Trm10p catalyzes modification of position 9, but not at position 37 (Fig. 3) . In addition, because only 1 mole of m 1 G is produced during modification of tRNA Gly transcript in vitro (Table 1) , because the modified site is known to be position 9 with the G 9 *Gly substrate (Fig. 2) , and because this is the only position known to be modified to m 1 G in tRNA Gly , we conclude that Trm10p primarily modifies G 9 in vitro.
Finally, we have shown that Trm10p is required in vivo for methylation of G 9 in 9 of the 10 yeast tRNAs known to have this modification, based on two results. First, a comparison of tRNA Gly purified from wild-type and trm10-⌬ cells shows that m 1 G modification is dependent on Trm10p (Fig. 5) . Second, RT pauses at position 10 in primer extension assays of 9 tRNAs species known to contain m 1 G 9 , but not if the tRNAs were isolated from an otherwise isogenic trm10-⌬/trm10-⌬ strain (Fig. 6 ).
There is a clear demarcation of position specificity for m 1 G modification by Trm10p at G 9 , as shown here, and by Trm5p at G 37 of substrate tRNAs (Bjork et al. 2001 ). This strict site specificity for what is essentially the same chemical reaction is similar to that observed with S. cerevisiae Tad1p and Tad2p/Tad3p, which are responsible for formation of I 37 and I 34 , respectively (Gerber et al. 1998; Gerber and Keller 1999) , and with Pus4p and Pus6p, which are responsible for formation of ⌿ 55 and ⌿ 31 , respectively (Becker et al. 1997; Ansmant et al. 2001) . Other tRNA modifications that occur at more than one position are catalyzed by proteins with region-specific modification activity, such as Pus3p, which forms ⌿ 38 and ⌿ 39 (Lecointe et al. 1998) , and Trm7p, which 2Ј-O-methylates at positions 32 and 34 (Tsai et al. 2002) . In contrast, some proteins exhibit promiscuous modification activity at multiple sites, such as Trm4p, which catalyzes m 5 C formation at positions 34, 40, 48, and 49 (Motorin and Grosjean 1999) , and Pus1p, which catalyzes ⌿ formation at up to eight widely different positions in tRNA substrates (Simos et al. 1996; Motorin et al. 1998) .
The mechanistic basis for the site specificity and catalysis of m 1 G modification by Trm5p and Trm10p is an intriguing question that remains to be addressed by further study. A search for homologs of each of these two S. cerevisiae proteins by BLAST yields a distinct family of enzymes for each one ( Fig. 7 ; data not shown). Independent alignments of these two predicted families of m 1 G methyltransferases yield core sequences of conserved amino acids within each group; however, none of these blocks of conserved sequence are shared between the two groups of enzymes. It is possible that Trm5p and Trm10p share a common chemical mechanism for m 1 G methylation but that the amino acids in the active site are hard to identify. Alternatively, the two enzymes may catalyze m 1 G modification in completely distinct ways. Further analysis of the mechanism of these two enzymes will help to address this question and may elucidate how Trm5p and Trm10p each recognize their different positions and tRNA substrates for m 1 G methylation.
Another intriguing specificity question is how Trm10p is able to distinguish between tRNA species to be modified and those to remain unmodified at position 9. Every eukaryotic tRNA sequenced to date contains a purine at position 9, with the exception of two tRNA His species, one FIGURE 8. Phylogeny of the Trm10p homologs. A phylogeny of the various Trm10p homologs from eukaryotes and archaea was constructed using the neighbor-joining method, rooted on the archaeal homologs. Bootstrap analysis was carried out using the PAUP* version 4.0b10, and bootstrap support (percentage of 1000 trials where a certain grouping was supported) is indicated at the respective nodes. The tree is collapsed to a 50% bootstrap support. The source species of each protein is listed beside the appropriate line, together with the corresponding accession number. , and tRNA Ala ), but there are 12 other tRNA species that contain a G at position 9 that remains unmodified in vivo (Sprinzl et al. 1998 ). There is no obvious primary sequence similarity in the region of position 9 that would explain m 1 G modification at this site. One possibility is that m 1 G 9 is formed either in response to, or to participate in, a common structural feature. An interaction involving the residue at position 9 has been observed in the crystal structure of tRNA Phe , in which a base-triple has been observed between an A at position 9 and the U 12 -A 23 base pair via a reverse-Hoogsteen interaction between the non-Watson-Crick faces (N7 and N6) of A 9 and A 23 (Kim et al. 1974 ). An investigation of the sequences of the 22 G 9 -containing elongator tRNAs from S. cerevisiae yields no sequence pattern for the base pair at position 12-23 that covaries with the modification status of G 9 that would indicate that m 1 G 9 participates in a similar structural feature (Sprinzl et al. 1998) . However, in eukaryotic initiator tRNAs position 9 is overwhelmingly found to be a G in eukaryotes (17 out of 18 tRNAs sequenced) and, moreover, that G is always modified to m 1 G (Sprinzl et al. 1998; Marck and Grosjean 2002) . Interestingly, the base pair at position 12-23 in the m 1 G 9 -containing tRNA i Met species is invariably a G 12 -C 23 base pair. Although the electron density of the m 1 G 9 in the crystal structure of S. cerevisiae tRNA i
Met is diffuse and therefore a specific interaction cannot be proven, it does appear to be in the correct position and orientation to interact with the G 12 -C 23 base pair in an analogous interaction to that observed between A 9 -A 23 -U 12 in tRNA Phe (Basavappa and Sigler 1991) . If such an interaction does occur, it may be that m 1 G 9 , although present in other tRNA species, plays its most important role in the correct structure or function of eukaryotic initiator tRNAs.
Trm10p is a highly conserved protein that is widely found in eukaryotes (Figs. 7, 8) , consistent with the widespread occurrence of m 1 G 9 in eukaryotic tRNAs. The finding of multiple paralogous proteins in some metazoans is unexpected, and raises the question of their origin and function. The fact that these multiple homologs are no more related to each other than to other members of the Trm10p family indicates that the duplication occurred prior to the divergence of eukaryotic species, implying that organisms such as yeast have lost the duplicated members after their divergence. It seems likely that at least one of the different paralogs in humans and other organisms is responsible for G 9 methylation of tRNAs. The other paralogs may have altered substrate specificity, contributing to m 1 G modification of specific subclasses of tRNAs or other RNAs, or they may have altered tissue specificity; alternatively, they may have evolved other functions. The presence of related archaeal homologs implies that they too may be m 1 G 9 methyltranferases, because at least one archaeal organism, Halobacterium cutirubrum, has tRNA with this modification (Gu et al. 1983) , although whether H. cutirubrum has a Trm10p homolog cannot be ascertained at this point owing to lack of sequence information.
We note that the pattern of m 1 G 9 modification in tRNAs from other eukaryotes is also not obvious, either by the subset of G 9 residues that are modified to m 1 G 9 , or by the identity of the tRNA species that are modified to m 1 G 9 in each organism. For example, the yeast tRNAs for Ala, Gly, Ile, Pro, Arg, Val, Trp, and initiator tRNA all contain m 1 G 9 , whereas in humans only Asn, Gln, and initiator tRNAs have been shown to have this modification, and at least one sequenced tRNA
Gly species has an unmodified G at position 9. All told, at least six other tRNAs (those for Asp, Glu, Met, Asn, Gln, and Thr) are modified with m 1 G 9 in some eukaryotes, but not in yeast. This indicates that the enzymes from different eukaryotes have evolved ways to distinguish between different sets of tRNAs to be modified, and may provide an explanation for why there are multiple paralogs of Trm10p in some metazoans. Cloning and analysis of other eukaryotic Trm10p homologs, particularly from species with multiple paralogs, will help to address these issues of specificity.
It is noteworthy that the extended superfamily of Trm5p homologs includes proteins that modify substrates other than tRNA, including rRNA and DNA. The finding of other methyltransferases in the Trm5 protein family, although still not identifying Trm10p, underscores their evolutionary unrelatedness. Although the Trm10 family of proteins is smaller, our phylogenetic analysis indicates that there may have been functional diversification in this family of proteins as well; further analysis of the multiple homologs present in metazoans will be required to elucidate any diverse functions.
The cellular role of m 1 G 9 modification is unclear at present, despite the evolutionary conservation of this modification and the conservation of the protein (Figs. 7, 8 ). Cells lacking Trm10p have no obvious growth defects under standard growth conditions in rich or minimal media. For a number of other mutants of tRNA modification enzymes, dramatic phenotypes are only manifested in combination with other mutations that alter tRNA modification or tRNA levels (Grosshans et al. 2001; Johansson and Bystrom 2002) . Further tests of this type may need to be done to clarify the role of Trm10 protein. The question of why this modification (and other modifications) is so widely conserved in eukaryotes is an important one because tRNA molecules are among the most abundant nucleic acids in the cell, and therefore a large amount of cellular energy is being spent on production of modifications. From our estimation of the number of mature tRNA molecules produced during a gen-eration of growth in S. cerevisiae, methylation at position 9 alone requires the consumption of ∼720,000 molecules of SAM per generation.
MATERIALS AND METHODS

Preparation of specifically labeled tRNA substrates tRNA
Gly specifically labeled at the phosphate following guanosine 9 (G 9 *Gly) was prepared as follows. In vitro transcribed tRNA Gly (1 nmole) was incubated with Rnase H (a gift from Y.-T. Yu, University of Rochester Medical Center) and a chimeric 2Ј-Omethylated/deoxy oligonucleotide (HHMI/Keck Center, Yale) to direct cleavage 3Ј of G 9 (Yu 1999) . After gel purification of the resulting 3Ј half-molecule, 100 pmole was treated with alkaline phosphatase (Roche), and then rephosphorylated with T4 Polynucleotide kinase (PNK; Roche) in the presence of [␥-32 P]ATP (ICN, 7000 Ci/mmole) to yield a labeled, 5Ј-phosphorylated 3Ј half-molecule (beginning at G 10 ) that was gel-purified. The labeled RNA (40-50 pmole) was ligated with a synthetic RNA comprising the first nine nucleotides of tRNA Gly (100-200 pmole; Dharmacon Research), using a DNA oligonucleotide (100-200 pmole) designed to bridge the desired ligation site, 80 U of T4 DNA ligase (USB), and incubation in buffer containing 1× T4 DNA ligase reaction buffer (USB) supplemented with an additional 1 mM ATP at 37°C for 4-12 h. Ligated RNA was purified by PAGE. Typical ligation efficiencies were 50%-70% of labeled 3Ј molecule ligated.
G 37 *Leu substrate was produced in essentially the same way, except that the chimeric oligonucleotide used in the RNase H reaction directed cleavage 3Ј of G 37 in in vitro transcribed mature tRNA CAA Leu , and the 5Ј half-molecule used for the subsequent ligation was PAGE-purified from the same RNase H reaction.
Primer extension assays were performed on the purified 3Ј fragments of RNA produced by RNase H to demonstrate that cleavage occurred at the correct position for each RNA. Ligated reaction products were analyzed by RNase T2 and P1 nuclease cleavage reactions to determine that the correct junction sequence was obtained after ligation.
Methyltransferase assay conditions m 1 G methyltransferase activity was assayed for both G 9 *Gly and G 37 *Leu tRNA substrates, in 10-µL reaction mixtures containing 50 mM Tris-HCl (pH 8.0), 2.5 mM MgCl 2 , 1 mM dithiothreitol (DTT), 50 mM ammonium acetate, 0.05 mM ethylenediaminetetraacetic acid (EDTA), 1 mM spermidine, 0.5 mM S-adenosylmethionine (SAM), 5000-10,000 cpm of the corresponding specifically labeled tRNA, and a source of m 1 G methyltransferase activity (crude extract or purified protein). Reactions were incubated at 30°C for 1-8 h as indicated, and then stopped by the addition of 90 µL of 0.5 M Tris-HCl (pH 8.0) containing 20 µg of carrier tRNA, followed by phenol extraction and ethanol precipitation of the RNA. RNA was resuspended in a 4-µL solution containing 20 mM ammonium acetate (pH 5.2), 1 mM EDTA, 10 µg of RNase A, and 1 U of RNase T2, and incubated at 50°C for 1 h, and then digestion products were applied to cellulose TLC plates (EM Science) and resolved in buffer containing saturated ammonium sulfate:isopropanol:water (80:18:2).
GST-ORF fusion proteins
The pools and subpools of purified GST-ORF fusion proteins were prepared as previously described (Martzen et al. 1999 ).
Strains and plasmids
The homozygous diploid strain deleted for YOL093w (trm10-⌬/ trm10-⌬) and its isogenic parent strain (BY4743) were obtained from Invitrogen. Plasmid pJEJ12-3 (N-terminal His 6 -Trm10p) was constructed by PCR amplification of the yeast TRM10 ORF, followed by insertion of the DNA into a pET-derived vector specifying the N-terminal sequence Met-Ala-His 6 before the first Met codon (gift of E. Grayhack, University of Rochester School of Medicine), and sequencing of the resulting insert.
Growth and preparation of crude yeast extracts
To prepare crude extracts, 250 mL of each strain was grown from single colonies in YPD media to an OD 600 of 2, and cells were harvested, resuspended in 1 mL of extraction buffer containing 50 mM Tris-HCl (pH 7.5), 1 mM EDTA, 4 mM MgCl 2 , 5 mM DTT, 10% glycerol, 1 M NaCl, with 2.5 µg/mL leupeptin and 2.5 µg/mL pepstatin, supplemented with 4 mM AEBSF and sheared with a bead-beater containing zirconium beads. Extracts were clarified by centrifugation; protein concentration was determined by BioRad protein assay, and samples were quick-frozen and stored at −80°C.
Purification of Trm10p
Plasmid pJEJ12-3 (N-terminal His 6 -Trm10p) was freshly transformed into E. coli BL21(DE3) pLysS cells (Novagen), and an individual transformant was grown at 37°C in 500 mL of LB containing 100 µg/mL ampicillin to OD 600 = 0.4, and induced for 5 h by the addition of 1 mM isopropyl ␤-D-thiogalactopyranoside (IPTG). Purification of His 6 -Trm10p was performed essentially as previously described (Steiger et al. 2001) , using TALON resin (Clontech) for immobilized metal-ion affinity chromatography (IMAC), except that the protein bound to the TALON resin was eluted using a gradient of 0-100 mM imidazole. Trm10p eluted as a single peak at ∼80-90 mM imidazole and was dialyzed into buffer containing 20 mM Tris-HCl (pH 7.5), 4 mM MgCl 2 , 2 mM EDTA, 55 mM NaCl, 1 mM DTT, and 50% glycerol for storage at −20°C. The purified protein (6.9 mg/mL) was estimated to be >95% pure on SDS-PAGE by Coomassie staining.
Preparation of small-molecular-weight RNA from yeast
To prepare RNA, the wild-type parent strain BY4743 (TRM10 + / TRM10 + ) and the trm10-⌬/trm10-⌬ strain were grown in 125 mL of YPD to an OD 600 of 2-3. Cells were harvested, and RNA was extracted with hot phenol, precipitated twice with ethanol, and resuspended in 1 mL of ddH 2 O essentially as described previously (Rubin 1975 ) and stored at −80°C. The concentration of the final purified RNA was calculated by assuming A 260 of 40 µg/mL RNA = 1.
Purification of tRNA
Gly from yeast . Binding of the biotinylated oligonucleotide to streptavidin (SA) magnetic particles (Roche) was performed according to the manufacturer's instructions. The tRNA Gly was purified from 1 mg of total cellular RNA using 2 mg of bound beads according to the method of Tsurui et al. (1994) . The eluted tRNA was centrifuged at 13,000 rpm for 10 min to remove any residual beads and desalted/concentrated by centrifugation using a Centricon YM-10 (Amicon) with successive concentration and dilution into ddH 2 O. The concentration of purified tRNA was determined using A 260 ; ∼10-15 µg of purified tRNA was recovered per milligram of total cellular RNA. The same procedure was used to individually purify tRNA CAA Leu from wildtype and trm10-⌬-derived RNAs using a biotinylated oligonucleotide complementary to the 3Ј-end of this tRNA.
HPLC analysis of nucleosides
Purified tRNA
Gly isolated from yeast (1 µg) or in vitro transcribed tRNA Gly (20 µg) incubated with Trm10p or buffer was treated with 4 µg of P1 nuclease in buffer containing 30 mM sodium acetate (pH 5.2) and 0.2 mM ZnCl 2 at 37°C for 16 h, and then with 8 U of calf intestinal alkaline phosphatase (Roche) in 1× alkaline phosphatase reaction buffer at 37°C for 3 h. The resulting nucleosides were resolved by HPLC (Waters Alliance Model 2690, equipped with Waters 996 photodiode array detector) on a reverse phase C18 column (supelcosil LC-18-T, 25 cm × 4.6 µm; Supelco, Inc.) essentially as described (Gehrke and Kuo 1989) , and individual spectra of the nucleosides were used to confirm the assignments. N-1 methylguanosine (m 1 G) was obtained from R.I. Chemical and analyzed in the same way.
Quantification of modified nucleosides was carried out by measuring the area under each nucleoside peak at its known maximum absorbance. The areas of the four main nucleosides (C, U, G, and A) were used to determine the total number of moles of tRNA in each injection by dividing the area observed by the known extinction coefficient for each nucleoside and then normalizing for the expected number of that nucleoside in the tRNA being analyzed. The moles of modified nucleotide in each injection were then determined by dividing the area by the known extinction coefficient for each modified nucleoside; this number was compared with the total moles of tRNA in the sample to obtain the ratio of modified nucleoside per tRNA.
Primer extension assays
Primer extension experiments were carried out using 15-20 nt primers (Integrated DNA Technologies) that were 5Ј-end-labeled with T4 PNK and [␥-32 P]ATP (ICN, 7000 Ci/mmole), followed by centrifugation through a MicroBioSpin 6 column (BioRad) to remove unincorporated ATP. In a 5-µL reaction containing 50 mM Tris-HCl (pH 8.3), 30 mM NaCl, and 10 mM DTT, 1 pmole of each primer was annealed with 2 µg of total RNA (isolated as described above) by heating to 95°C for 3 min followed by slow cooling to 37°C. Then 2 µL of annealed RNA/primer was added to a 5-µL reaction containing 0.1-0.4 mM each dNTP (G, A,T, and C) and 0.7 U of AMV-Reverse transcriptase (Promega, high concentration) in 1× AMV-RT reaction buffer (Promega). Sequencing reactions additionally contained 0.2 mM of each ddNTP (G, A, T, or C) as indicated. After 5 min at room temperature, extensions were allowed to continue at 37°C for 30 min-1 h and then stopped by the addition of 7 µL of formamide containing 0.2 mg/mL carrier RNA, 0.1% bromophenol blue, and 0.1% xylene cyanol. Reactions were run on 10% polyacrylamide, 4 M urea gels and visualized using the PhosphorImager (Molecular Dynamics).
Bioinformatics and phylogenetic analysis
Using the yeast Trm10p as the query sequence, PSI-BLAST searches were carried out (Altschul et al. 1997) . These led to the identification of archaeal homologs in the second iteration, which were also used as queries in subsequent PSI-BLAST analyses to obtain a comprehensive list of Trm10p homologs. To ascertain if there was any homology between the m 1 G 9 and m 1 G 37 methyltransferases, we used the Blocks database (http://blocks.fhcrc.org; Henikoff et al. 2000) ; preconstructed blocks corresponding to the m 1 G 37 methyltransferases (IPB002905) were used as queries to search both the list of individual Trm10p homologs using PSI-BLAST, or consensus blocks constructed from the Trm10p homologs, using a LAMA search (Pietrokovski 1996) . In neither case was any significant homology found. The Trm10p homologs were aligned using CLUSTALX (Thompson et al. 1997) ; the alignment was used to generate a phylogeny using the neighbor-joining program (Saitou and Nei 1987) , and bootstrap analysis was carried out in the PAUP* suite (Swofford 2002) .
